1. The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis

   • Dimitrios C. Ladakis
   • Pavan Bhargava

   Leading Article 24 January 2023 Pages: 117 - 132

2. Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature

   • Senta Frol
   • Mišo Šabovič
   • Janja Pretnar Oblak

   Systematic Review 17 January 2023 Pages: 133 - 141

   

3. Estimating Risk of Antidepressant Withdrawal from a Review of Published Data

   • Mark Abie Horowitz
   • Adele Framer
   • David Taylor

   Review Article Open access 14 December 2022 Pages: 143 - 157

   

4. Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation

   • Jules S. Mitchell
   • Daniel F. Hermens
   • Jim Lagopoulos

   Review Article Open access 22 January 2023 Pages: 159 - 180

   

5. Teriflunomide Concentrations in Cerebrospinal Fluid and Plasma in Patients with Multiple Sclerosis: A Pharmacokinetic Study

   • Jan Lycke
   • Helen Farman
   • Anna Nordin

   Original Research Article Open access 02 February 2023 Pages: 181 - 188

   

6. Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine

   • Luigi Francesco Iannone
   • Davide Fattori
   • Francesco De Cesaris

   Original Research Article 19 January 2023 Pages: 189 - 202